S

Sarepta Therapeutics

1228 employees

Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.

Investor insights

Sectors invested in

Therapeutics4
Biotechnology4
Health Care2
Gene Therapy1
Life Science1
Genetics1
Information Technology1
AAV capsid engineering1
CNS disease1
AAV gene therapy1
AAV capsid variants1
Lysosomal storage disease1
AAV manufacturing1
AAV Vectors1

Funding rounds participated in

$60M sweet spot round size

Most of their 4 investments are in rounds between $30M and $60M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Genetics

Date founded

1980

Investments made

L

LEXEO Therapeutics raised undisclosed on August 28, 2023

Investors: Sarepta Therapeutics

S

StrideBio, Inc raised $82M on March 16, 2021

Investors: UCB Ventures, Octagon Capital Advisors, Northpond Ventures, UF Innovate | Ventures, Novo Holdings, Takeda UK Limited, CaaS Capital Management, Pontifax Venture Capital and Sarepta Therapeutics

L

Lacerta Therapeutics raised $30M on August 9, 2018

Investors: Sarepta Therapeutics

M

Myonexus Therapeutics, Inc. raised $60M on May 8, 2018

Investors: Sarepta Therapeutics

Funding rounds raised

Total raised

$400M

from 3 investors over 3 rounds

S

Sarepta Therapeutics raised $400M on February 14, 2020

Investors: Roche Financial

S

Sarepta Therapeutics raised $250M on December 13, 2019

Investors: Pharmakon Advisors, LP

S

Sarepta Therapeutics raised $100M on July 19, 2017

Investors: MidCap Financial

FAQ